Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-PIOGLITAZONE | 15MG | TABLET | Resolved | 2019-07-04 | 2023-01-03 | 88502 |
| MINT-PIOGLITAZONE | 30MG | TABLET | Resolved | 2019-10-09 | 2023-01-03 | 95924 |
| MINT-PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-04-25 | 2023-01-03 | 113196 |
| MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27153 | ||
| MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27157 | ||
| MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27161 | ||
| MINT-PREGABALIN | 50MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-17 | 35501 |
| MINT-QUETIAPINE | 100MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46033 |
| MINT-QUETIAPINE | 200MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46038 |
| MINT-QUETIAPINE | 300MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46041 |
| MINT-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217384 |
| MINT-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217387 |
| MINT-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217390 |
| MINT-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217393 |
| MINT-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217396 |
| MINT-RISPERIDON | 3.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122513 |
| MINT-RISPERIDON | 4.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122516 |
| MINT-RAMIPRIL | 15.0MG | CAPSULE | Resolved | 2020-08-19 | 2021-01-11 | 122510 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71087 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95927 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |